www.nucleusnetwork.com Open in urlscan Pro
52.58.254.253  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 
Contact Participate in a trial
Menu Close



ADVANCING MEDICINE, IMPROVING LIVES.

Do you want to be reimbursed up to $600/day for your time? Participate in one of
our clinical trials and help to develop new medication that can help the lives
of millions of people!


Brisbane • Melbourne • Minneapolis


Discover our Melbourne studies Discover our Brisbane studies


DISCOVER OUR CURRENT STUDIES

We have a wide variety of studies, ranging from stays of 2 days/nights to stays
of multiple weeks. We are looking for healthy volunteers, but also people with a
variety of medical conditions. Take a look at our current studies and find the
one that's best for you!

Discover our studies



DO YOU HAVE ANY QUESTIONS?

At Nucleus Network we run early-stage clinical trials for some of the world’s
leading pharmaceutical and biotechnology companies. Do you have questions about
how clinical trials work or what it’s like to take part in one? We are always
happy to speak to potential participants at 1300 308 905

Give us a call today



PARTICIPATING IN A CLINICAL TRIAL

Do you want to know more about what it's like to participate in one of our
trials? Just watch this short video!

Discover some of our priority studies here. For a more complete list of our
currently recruiting studies, go here for Melbourne and here for Brisbane.


 * Melbourne Studies
 * Brisbane Studies

 * Study name
 * Eligibility
 * Status
 * Overnight stays
 * Outpatient visits
 * 

 * Study name The Kidney Study
   Eligibility
    * Biological sex Healthy males and females of non-childbearing potential
    * Age 18 – 65 years old
    * BMI 18–32 kg/m2
    * Weight Weigh more than 45kg for females and more than 50kg for males
    * Medication Not taking any medication
    * Medical History No significant medical history
    * Asthma History No history of adult asthma
   
   Status Currently Recruiting
   Overnight stays 3 overnight stays + 1 set of 2- nights
   Outpatient visits 1 phone call + 12 visits
   View study details

 * Study name The Lower Cholesterol Study
   Eligibility
    * Biological Sex Healthy males and females
    * Age 18 – 65 years old
    * BMI 18.5 – 35.0kg/m²
    * Medication Not taking any medication
    * Medical History Have known or suspected slightly elevated cholesterol
      levels
    * Smoking History Non-smoker in past 3 months or casual smoker up to 5 per
      week
   
   Status Currently Recruiting
   Overnight stays 2 nights
   Outpatient visits 8 visits
   View study details

 * Study name The Inhibitor Study
   Eligibility
    * Biological Sex Healthy males and females
    * Age 18 - 55 years old
    * BMI 18 - 32kg/m²
    * Medical History No significant medical history
    * Medications Not taking any medication
    * Smoking History Non-smokers or smokers who smoke less than 10 per week
   
   Status Currently Recruiting
   Overnight stays 9 + 2 x 1 + 5 nights
   Outpatient visits 7 + 2 vaccine visits
   View study details

Primary button


OUR UNIQUE OFFERING


Nucleus Network is the only Phase 1 clinical research organization in the world
to have Phase 1 facilities located in Australia and the USA. We are Australia’s
largest Phase 1 clinical research organization and one of the few specialized
units in the USA capable of delivering Phase 1 hepatic and renal clinical
trials.

Nucleus Network is uniquely positioned to help administer your clinical trial
with our four key advantages:



SPECIALIZATION

Each of our Phase 1 facilities have focused areas of specialization and
extensive internal and external capabilities to support the complex requirements
of Phase 1 clinical trials.

Read More


EXPERTISE

Our Phase 1 facilities are supported by a highly trained and dedicated team of
medical personnel (FRACP), including clinical pharmacologists, oncologists,
nephrologists and infectious disease physicians.

Read More


LOCATION

Our Australian Phase 1 facilities are strategically co-located within prominent
Hospitals and our USA Phase 1 facility benefits from co-locating within a Life
Sciences and Biomedical Research Precinct.

Read More


QUALITY

The data generated from Nucleus Network is used to support IND and NDA
regulatory filings for the USA FDA. Data is also used for EMA, PMDA and Health
Canada regulatory filings.

Read More

In excess of

1,000+

Phase 1 clinical trials conducted



Annually conducting

100

Clinical Pharmacology trials across three clinics



Including

50

true first-in-human studies completed annually



More than

20

years’ experience conducting Phase 1 clinical trials



Over

200+

Phase 1 clinical trial beds



Hosted over

200+

sponsor audits, including FDA and EMA regulatory inspections



Access to over

11.9 million

total population across Brisbane and Melbourne (Australia)



As well as

5.7 million

total population across Minneapolis – Saint Paul (USA)



In-house

210,000+

qualified participant database




CONDUCT YOUR CLINICAL TRIAL WITH US

Contact us

In the spirit of reconciliation Nucleus Network acknowledges the Traditional
Custodians of country throughout Australia and their connections to land, sea
and community. We pay our respect to their Elders past and present and extend
that respect to all Aboriginal and Torres Strait Islander peoples today. We
acknowledge their contributions to medicine, science and public health.


Clinical Trial Solutions
 * Our Expertise
 * Our Multi-Country Advantage
 * Our Facilities
 * Our Quality Assurance

About Us
 * Our Leadership Team
 * Our Medical Team
 * Our History
 * Join Our Team

Contact
Participate in a trial

--------------------------------------------------------------------------------

© Copyright Nucleus Network

Privacy Policy
Website designed by Thirst Creative










We use our own cookies and third-party cookies so that we can show you this
website and better understand how you use it, with a view to improving the
services we offer. By continuing to browse our website, we consider that you
have accepted the cookies.
Accept